Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention

Epidermal growth factor receptor (EGFR) mutations occur in about 50% of lung adenocarcinomas in Asia and about 15% in the US. EGFR mutation-specific inhibitors have been developed and made significant contributions to controlling EGFR mutated non-small cell lung cancer. However, resistance frequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jing, Xiong, Donghai, Zhang, Qi, Palen, Katie, Shoemaker, Robert H., Johnson, Bryon, Sei, Shizuko, Wang, Yian, You, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982083/
https://www.ncbi.nlm.nih.gov/pubmed/36875137
http://dx.doi.org/10.3389/fimmu.2023.1036563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982083/
https://www.ncbi.nlm.nih.gov/pubmed/36875137
http://dx.doi.org/10.3389/fimmu.2023.1036563

Ejemplares similares